Bridgefront Capital, LLC Novo Nordisk A S Transaction History

Bridgefront Capital, LLC

  • $249 Million
  • Q3 2024

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2023

Aug 14, 2023
BUY
$155.98 - $172.65 $323,970 - $358,594
2,077 New
2,077 $336,000
Q2 2021

Aug 12, 2021
SELL
$67.66 - $84.76 $825,452 - $1.03 Million
-12,200 Closed
0 $0
Q1 2021

May 17, 2021
BUY
$67.06 - $75.82 $589,859 - $666,912
8,796 Added 258.4%
12,200 $823,000
Q4 2020

Feb 12, 2021
BUY
$63.89 - $73.8 $217,481 - $251,215
3,404 New
3,404 $238,000

Others Institutions Holding NVO

# of Institutions
1,956
Shares Held
320M
Call Options Held
5.49M
Put Options Held
7.78M
View Full List

About NOVO NORDISK A S

NVO Quotes by TradingView
  • Ticker NVO
  • Exchange OTC
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 2,257,289,984
  • Market Cap $244B
  • Description
  • Novo Nordisk A/S, a healthcare company, engages in the research, development, manufacture, and marketing of pharmaceutical products worldwide. It operates in two segments, Diabetes and Obesity care, and Biopharm. The Diabetes and Obesity care segment provides products in the areas of insulins, GLP-1 and related delivery systems, oral antidiabeti...
More about NVO
Track This Portfolio

Track Bridgefront Capital, LLC Portfolio

Follow Bridgefront Capital, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Bridgefront Capital, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Bridgefront Capital, LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email